CONTEXT: Fetuin-A inhibits the insulin receptor in vitro. Higher serum fetuin-A concentrations are associated with type 2 diabetes longitudinally and greater adiposity in cross-sectional analyses. Whether higher fetuin-A concentrations are associated with accumulation of adiposity over time is unknown. OBJECTIVE: To determine the association of fetuin-A levels with changes in body composition over 5 yr. STUDY DESIGN: Observational cohort study nested in the Health Aging and Body Composition Study. PREDICTOR: Serum fetuin-A levels. OUTCOMES: Visceral adipose tissue (VAT), abdominal sc adipose tissue, and thigh muscle area by computed tomography, and waist circumference and body mass index were measured at baseline and again after 5 yr. Percent change and extreme change (>1.5 sds) in each measure were calculated. RESULTS: Over 5 yr, subjects lost body mass in each measure, including 6% decline in VAT. Yet each sd (0.42 g/liter) higher fetuin-A concentration was associated with a 5.5% increase in VAT over 5 yr (95% confidence interval 1.9-9.2%; P = 0.003) in models adjusted for age, sex, race, clinical site, diabetes, physical activity, triglycerides, kidney function, and the baseline VAT score. Similarly, higher fetuin-A concentrations were associated with extreme VAT gain (relative risk 1.70, 95% confidence interval 1.12-2.60, P = 0.01). Fetuin-A concentrations were not statistically significant associated with change in any other measures of body composition (P > 0.20). CONCLUSIONS: Higher fetuin-A concentrations are associated with the accumulation of VAT in well-functioning, community-living older persons. The mechanisms linking fetuin-A, VAT, and insulin resistance remain to be determined.
CONTEXT: Fetuin-A inhibits the insulin receptor in vitro. Higher serum fetuin-A concentrations are associated with type 2 diabetes longitudinally and greater adiposity in cross-sectional analyses. Whether higher fetuin-A concentrations are associated with accumulation of adiposity over time is unknown. OBJECTIVE: To determine the association of fetuin-A levels with changes in body composition over 5 yr. STUDY DESIGN: Observational cohort study nested in the Health Aging and Body Composition Study. PREDICTOR: Serum fetuin-A levels. OUTCOMES: Visceral adipose tissue (VAT), abdominal sc adipose tissue, and thigh muscle area by computed tomography, and waist circumference and body mass index were measured at baseline and again after 5 yr. Percent change and extreme change (>1.5 sds) in each measure were calculated. RESULTS: Over 5 yr, subjects lost body mass in each measure, including 6% decline in VAT. Yet each sd (0.42 g/liter) higher fetuin-A concentration was associated with a 5.5% increase in VAT over 5 yr (95% confidence interval 1.9-9.2%; P = 0.003) in models adjusted for age, sex, race, clinical site, diabetes, physical activity, triglycerides, kidney function, and the baseline VAT score. Similarly, higher fetuin-A concentrations were associated with extreme VAT gain (relative risk 1.70, 95% confidence interval 1.12-2.60, P = 0.01). Fetuin-A concentrations were not statistically significant associated with change in any other measures of body composition (P > 0.20). CONCLUSIONS: Higher fetuin-A concentrations are associated with the accumulation of VAT in well-functioning, community-living older persons. The mechanisms linking fetuin-A, VAT, and insulin resistance remain to be determined.
Authors: D Gallagher; E Ruts; M Visser; S Heshka; R N Baumgartner; J Wang; R N Pierson; F X Pi-Sunyer; S B Heymsfield Journal: Am J Physiol Endocrinol Metab Date: 2000-08 Impact factor: 4.310
Authors: Annemarie Koster; Sari Stenholm; Dawn E Alley; Lauren J Kim; Eleanor M Simonsick; Alka M Kanaya; Marjolein Visser; Denise K Houston; Barbara J Nicklas; Frances A Tylavsky; Suzanne Satterfield; Bret H Goodpaster; Luigi Ferrucci; Tamara B Harris Journal: Obesity (Silver Spring) Date: 2010-04-15 Impact factor: 5.002
Authors: Joachim H Ix; Mary L Biggs; Kenneth J Mukamal; Jorge R Kizer; Susan J Zieman; David S Siscovick; Dariush Mozzaffarian; Majken K Jensen; Lauren Nelson; Neil Ruderman; Luc Djousse Journal: Circulation Date: 2012-04-17 Impact factor: 29.690
Authors: Xiaowen Liu; Ole-Petter R Hamnvik; John P Chamberland; Michael Petrou; Huizhi Gong; Costas A Christophi; David C Christiani; Stefanos N Kales; Christos S Mantzoros Journal: Metabolism Date: 2014-03-15 Impact factor: 8.694
Authors: Steven K Malin; Anny Mulya; Ciaran E Fealy; Jacob M Haus; Mangesh R Pagadala; Amanda R Scelsi; Hazel Huang; Chris A Flask; Arthur J McCullough; John P Kirwan Journal: J Appl Physiol (1985) Date: 2013-08-08
Authors: Unhee Lim; Stephen D Turner; Adrian A Franke; Robert V Cooney; Lynne R Wilkens; Thomas Ernst; Cheryl L Albright; Rachel Novotny; Linda Chang; Laurence N Kolonel; Suzanne P Murphy; Loïc Le Marchand Journal: PLoS One Date: 2012-08-17 Impact factor: 3.240